BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27030990)

  • 21. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma.
    Guo R; Mao YP; Chen L; Tang LL; Zhou GQ; Liu LZ; Tian L; Zeng MS; Jia WH; Shao JY; Lin AH; Ma J
    Oncotarget; 2017 Feb; 8(6):10594-10601. PubMed ID: 27070084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-treatment serum lactic dehydrogenase as a predictive indicator for distant metastasis and survival of patients with nasopharyngeal carcinoma.
    Wang J; Li L; Dong BQ; Xu YJ; Zheng YD; Sun ZW; Yang Y; Chen YY; Chen XZ; Chen M
    Oncotarget; 2016 May; 7(19):27458-67. PubMed ID: 27050275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherently poor survival of elderly patients with nasopharyngeal carcinoma.
    Zhang Y; Yi JL; Huang XD; Xu GZ; Xiao JP; Li SY; Luo JW; Zhang SP; Wang K; Qu Y; Gao L
    Head Neck; 2015 Jun; 37(6):771-6. PubMed ID: 24115004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posterior cervical lymph node metastasis as the valuable prognostic factor for stage IVA/IVB nasopharyngeal carcinoma treated with induction chemotherapy followed by concurrent chemo-radiotherapy.
    Thephamongkhol K; Setakornnukul J; Rojwatkarnjana S; Chansilpa Y
    Int J Biol Markers; 2014 Dec; 29(4):e387-94. PubMed ID: 25198554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.
    Chen PC; Liu WS; Huang WL; Wu CJ; Yang CC; Lee CC
    Radiat Oncol; 2016 Apr; 11():62. PubMed ID: 27117713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.
    Kwong DL; Sham JS; Chua DT; Choy DT; Au GK; Wu PM
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):703-10. PubMed ID: 9336153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time.
    Langendijk JA; de Jong MA; Leemans CR; de Bree R; Smeele LE; Doornaert P; Slotman BJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):693-700. PubMed ID: 14529773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinoma.
    Fangzheng W; Chuner J; Lei W; Weijun C; Min X; Quanquan S; Tongxin L; Aizawa R; Sakamoto M; Zhenfu F
    Oncotarget; 2017 Jun; 8(24):39756-39765. PubMed ID: 28055973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
    Ou X; Miao Y; Wang X; Ding J; He X; Hu C
    Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma treated with IMRT: a retrospective study.
    Su Z; Mao YP; Tang J; Lan XW; OuYang PY; Xie FY
    Tumour Biol; 2016 Apr; 37(4):4429-38. PubMed ID: 26499947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area.
    Huang PY; Zeng Q; Cao KJ; Guo X; Guo L; Mo HY; Wu PH; Qian CN; Mai HQ; Hong MH
    Eur J Cancer; 2015 Sep; 51(13):1760-70. PubMed ID: 26093812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis.
    Chien CR; Lin HW; Yang CH; Yang SN; Wang YC; Kuo YC; Chen SW; Liang JA
    Clin Otolaryngol; 2011 Dec; 36(6):558-65. PubMed ID: 22023959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
    Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
    Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T4/N2 classification nasopharyngeal carcinoma benefit from concurrent chemotherapy in the era of intensity-modulated radiotherapy.
    Xie R; Xia B; Zhang X; Hu W; Zhao R; Xie C; Wang J; Zhang N; Wu S
    Oncotarget; 2016 Dec; 7(49):81918-81925. PubMed ID: 27636993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
    Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
    Chua DT; Nicholls JM; Sham JS; Au GK
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):11-20. PubMed ID: 15093894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.